Mesenchymal stem cells in the treatment of ischemic stroke: progress and possibilities

Stroke is a major cause of death and long-term disability in industrialized countries, and the only causal therapy for stroke comprises recombinant tissue plasminogen activator(rt-PA)-mediated recanalization of the occluded vessel. New experimental strategies focus on neuroregenerative approaches, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Doeppner, Thorsten R, Hermann, Dirk M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781740/
https://www.ncbi.nlm.nih.gov/pubmed/24198521
http://dx.doi.org/10.2147/SCCAA.S7820

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781740/
https://www.ncbi.nlm.nih.gov/pubmed/24198521
http://dx.doi.org/10.2147/SCCAA.S7820

Ejemplares similares